Atrial Fibrillation Market Growth Driven by Technological Advancements in AFib Systems and Solutions and Rapidly Increasing Geriatric Population - Reports and Data

NEW YORK, Nov. 16, 2021 /PRNewswire/ -- The global atrial fibrillation market size is expected to reach USD 2.11 billion in 2028 and register a CAGR of 6.4% during the forecast period, according to the latest report by Reports and Data. Rising global prevalence of atrial fibrillation, advancements in research to identify modifiable AFib risk factors, and growing focus on targeted prevention programs to manage atrial fibrillation at early stages are key factors expected to drive market revenue growth over the forecast period. In addition, awareness about atrial fibrillation and its detection has improved significantly over the recent past and has led to further development of more robust treatment strategies to reduce mortality and morbidity associated with this condition.

Download Report Summary PDF - https://www.reportsanddata.com/download-summary-form/1440

Atrial fibrillation is the most commonly detected arrhythmia in modern clinical practice and is responsible for nearly 30% of the hospital admissions related to cardiac rhythm problems. Global prevalence of atrial fibrillation is rising steadily and the healthcare burden as a result has been increasing owing to higher rates of atrial fibrillation-related hospital admissions. Atrial fibrillation leads to a chaotic or abnormal blood flow through heart chambers and the loss of effective atrial contraction leads to a 15-20% reduction in cardiac output. Obesity, Obstructive Sleep Apnea (OSA), hypertension, genetic predisposition, and valvular heart disease are some of the major risk factors with atrial fibrillation. Atrial fibrillation is associated with a significant increase in long-term risk of stroke, heart failure, and impaired quality of life. This has led to growing need for a renewed approach to AFib management and in turn has increased focused on modifying the risk factors for atrial fibrillation along with adjuvant drug therapy. Recent advancements in medical technology has resulted in greater understanding of atrial fibrillation and the mechanism of its onset, and this is expected to further drive revenue growth of the market over the forecast period.

Atrial fibrillation has been categorized into three primary forms based on the duration of the episode and these include paroxysmal AF, persistent AF, and long standing persistent AF. It is important to identify and determine the clinical significance of arrhythmia before the atrial fibrillation is to be treated. In addition, the field of AFib is evolving rapidly with the development of percutaneous and surgical interventional therapies as safe and viable alternatives to restore normal cardiac rhythm. Minimally invasive surgical modifications and the advent of hybrid ablation have further revolutionized the development of stand-alone procedures to cure atrial fibrillation with reduced morbidity. This is also expected to contribute significantly to revenue growth of the market going ahead. However, lack of awareness and understanding among patients about atrial fibrillation, need for more advanced healthcare facilities, and shortage of skilled professionals are some key factors expected to restrain market growth to a certain extent going ahead.

To identify the key trends in the industry, research study at https://www.reportsanddata.com/report-detail/atrial-fibrillation-market

Some Key Highlights from the Report:

·  Catheter ablation has been widely used to treat atrial fibrillation as an alternative to medical management and is effective for patients having persistent AFib and systolic dysfunction. Catheter ablation is an effective option to improve survival in patients with ventricular dysfunction, improve quality of life, and reduce arrhythmia-related hospital admissions. This has led to increasing preference for electrophysiology and cardiac ablation for the treatment of atrial fibrillation and is expected to contribute steadily to revenue growth of the segment.

• Ambulatory surgical centers segment revenue is expected to expand at a robust CAGR over the forecast period, which is attributable to increasing preference for same-day surgical care, accessibility to cost-effective surgical procedures, and availability of convenient alternative to hospital-based outpatient settings.
• Asia Pacific is expected to register a robust revenue CAGR over the forecast period, which is attributable to increasing incidence of atrial fibrillation among a rapidly increasing geriatric population, availability of advanced medical devices and equipment and skilled professionals, rising investment to accelerate R&D activities, development of robust atrial fibrillation medical management plans, and growing adoption of atrial fibrillation treatment devices I major countries in the region.
• Some major companies in the market report include Abbott Laboratories, Atricure Inc., Johnson & Johnson, Microport Scientific Corporation, Boston Scientific Corporation, Biosense Webster, Inc., St. Jude medical, Inc., Siemens AG, Medtronic Plc, Koninklijke Philips N.V., Cardiofocus, Inc., Biotitic Se & Co. Kg, Inc., Carima, Inc., Ncontact, Inc., and Agricore, Inc.
• In October 2021, Ascension Sacred Heart Bay, which is an acute care hospital based in Florida, U.S., introduced a novel procedure to treat patients with cardiac issues with a small implantable device. The procedure can significantly minimize the risk of stroke in patients with atrial fibrillation that is generally not caused due to valve problems.

Ask for Customize Research Report @ https://www.reportsanddata.com/request-customization-form/1440

For the purpose of this report, Reports and Data has segmented the global atrial fibrillation market based on type, end-use, and region:

Type Outlook (Revenue, USD Billion; 2018-2028)

• EP Ablation Catheters
• Cardiac Monitors
• EP Diagnostic Catheter
• Mapping and Recording Systems
• Access Devices
• Intracardiac Echocardiography

End-Use Outlook (Revenue, USD Billion; 2018-2028)

• Hospitals
• Cardiac Centers
• Ambulatory Care Centers

Buy Premium Research Report @ https://www.reportsanddata.com/checkout-form/1440

Regional Outlook (Revenue, USD Billion; 2018-2028)

• North America
• U.S.
• Canada
• Mexico
• Europe
• Germany
• U.K.
• France
• Italy
• BENELUX
• Rest of Europe
• Asia Pacific
• China
• India
• Japan
• South Korea
• Rest of APAC
• Latin America
• Brazil
• Rest of LATAM
• · Middle East & Africa
• Saudi Arabia
• U.A.E.
• South Africa
• Rest of MEA

Explore Latest Published Reports by Reports and Data:

Legal Marijuana Market By Product Type (Marijuana Flower, Extracts), By Strain (CBD-dominant, THC-dominant, Balanced CBD and THC), By Application (Recreational, Medical, Cosmetics, Others), By Species (Sativa, Indica, Hybrid), and By Region, Forecast to 2028

Blood Collection Market By Product (Needles & Syringes, Blood Collection Tubes, Blood Bags, Lancets, Blood Collection Systems & Monitors), By Application (Diagnostics, Therapeutics), By End-Use (Hospitals & Nursing Homes, Blood Banks, Diagnostics Centers & Laboratories, Others), and By Region Forecasts To 2028

Track Etched Membrane Market Size, Share & Analysis, By Product (Membrane Filters, Capsule & Cartridge Filters, Others), By Material (Polycarbonate, Polyethylene Terephthalate, Polyimide), By Application (Cell Biology, Microbiology, Analytical Testing, Others), By End-Use Industry, And By Region, Forecast To 2028

Neuroscience Antibodies and Assays Market Size, Share & Analysis, By Product (Consumables (Reagents, Antibodies, Assay Kits), Instruments), By Technology (Immunoassays, Molecular Diagnostics, Clinical Chemistry, Others), By Application (Research, In Vitro Diagnostics, Drug Discovery & Development), By End-Use, and By Region, Forecast To 2028

Hematologic Malignancies Market Size, Share & Analysis, By Type (Leukemia, Lymphoma, Multiple Myeloma, Others), By Therapy (Chemotherapy, Radiotherapy, Immunotherapy, Stem Cell Transplantation), And By Region, Forecast To 2028

Disruptive Behavior Disorder Treatment Market Size, Share & Analysis, By Type (Intermittent Explosive Disorder, Conduct Disorder, Oppositional Defiant Disorder), By Treatment (Medication Management, Parenting Modification, Social & Emotional Skills Training, Comprehensive Evaluation, Individual Therapy, Family Therapy, Group Therapy), And By Region Forecast To 2028

About Reports and Data        

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.

Contact Us:

John W
Head of Business Development
Reports And Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: [email protected]
LinkedIn | Twitter | Blogs

Read Latest Press Release @ https://www.reportsanddata.com/press-release/global-atrial-fibrillation-market

SOURCE Reports And Data